Cargando…
Galectin-3 as an early marker of diastolic dysfunction in children with end-stage renal disease on regular hemodialysis
INTRODUCTION AND AIM : Diastolic dysfunction is a common finding in end-stage renal disease (ESRD) on regular hemodialysis (HD). Galectin-3 (Gal-3) has emerged as an early biomarker with diagnostic and prognostic values in cardiac dysfunction with reduced or preserved ejection fraction. We aimed to...
Autores principales: | Elsadek, Akram, Ibrahim, Mohamed, El Fallah, Asmaa Adel, Elian, Mohamed, Deraz, Salem Elsayed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802609/ https://www.ncbi.nlm.nih.gov/pubmed/36589658 http://dx.doi.org/10.4103/apc.apc_146_21 |
Ejemplares similares
-
Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
por: Deraz, Salem Elsayed, et al.
Publicado: (2023) -
Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction
por: Ansari, Uzair, et al.
Publicado: (2018) -
Efficacy evaluation of serum galectin-3 in hypertension complicated with diastolic dysfunction
por: Dong, Tianwei, et al.
Publicado: (2020) -
The effect of Hepatitis C Virus infection on cardiovascular complications in end stage kidney disease patients on regular hemodialysis
por: Zaki, Mohamed Salah Eldin
Publicado: (2017) -
Risk factors of left ventricular diastolic dysfunction in maintenance hemodialysis patients
por: Lei, Ying, et al.
Publicado: (2023)